Subdermal Contraceptive Implants Market Size (2024 – 2030)

The Global Subdermal Contraceptive Implants Market was valued at USD 1.35 billion in 2023 and is projected to reach a market size of USD 3.08 billion by the end of 2030. The market is anticipated to expand at a compound annual growth rate (CAGR) of 12.5% between 2024 and 2030.

Under local anesthesia, tiny plastic rods the size of matchsticks called subdermal contraceptive implants are placed beneath the skin on the inside of the upper arm. After being implanted, it delivers the progestin hormone etonogestrel on an average of 50 mcg per day for three to five years. Even during unprotected intercourse, birth control, and contraception are effectively provided by the implant's progesterone release. Before removing or installing the contraceptive implant, medical professionals undergo a three-hour training program offered by the manufacturer. These days, an insertion applicator is used to inject subdermal contraceptives, avoiding the necessity for an incision and deep implant implantation. In case you missed it, subdermal contraceptive implants are radiopaque, meaning that they are simple to find and remove. Any time during the menstrual cycle, a girl can have a subdermal contraceptive implant placed in her body. The first five days of the menstrual cycle are often when it is implanted. Amenorrhea, headaches, and irregular vaginal bleeding are among the negative effects of subdermal contraceptives. To remove the implant, a bodily incision must be performed. Following this, ovarian activity returns to normal right away.

Key Market Insights:

47.0 million women lost contraception access during COVID-19, resulting in 7.0 million unintended pregnancies. Globally, half of pregnancies are unintended, with 60.0% leading to abortion and 45.0% being unsafe. Ethiopia faces significant reproductive health issues, with 38% of pregnancies unintended, resulting in 620,296 induced abortions yearly. Approximately 842 million women worldwide utilize contemporary forms of contraception, according to data from the UN Department of Economic and Social Affairs. The fact that only 2% of women use implants, however, is somewhat impeding the market's growth. Increasing demand for contraceptives due to rising unintended pregnancies propels market growth. Rising infertility prevalence, lack of awareness, and adverse effects of implants restrain market growth.

Global Subdermal Contraceptive Implants Market Drivers:

Subdermal contraceptive implants are a step forward in the freedom of fertility control, providing empowered choices.

Subdermal contraceptive implants are becoming more and more popular, which is contributing to a dramatic shift in the contraception landscape toward empowerment and freedom of choice. The reason for this market boom is the growing need for flexible birth control methods that suit the various interests and lifestyles of women. In contrast to traditional techniques like monthly injections or daily pills, subdermal implants offer women the ease of a set-and-forget approach with a hassle-free, long-lasting solution. This increased autonomy in reproductive healthcare is indicative of a larger social movement in favor of informed decision-making and tailored medicine. The underlying human need for control over fertility and reproductive choices is driving the subdermal implant industry, which is expected to rise in tandem with the expansion of healthcare facilities and information accessibility.

The High Efficacy Surge in Subdermal Implants is Fulfilling Demand.

The market for subdermal contraceptive implants is seeing a notable upswing in the field of contraception due to its exceptional effectiveness. These devices offer a level of reliability that customers find more desirable, with near-perfect prevention rates when used appropriately. Subdermal implants have a distinct advantage over other birth control techniques because of their emphasis on efficacy, which motivates people looking for a reliable form of birth control. In addition to giving consumers confidence, this kind of dependability is attractive and has a strong driving force behind industry growth. These implants are becoming increasingly popular because of their convenience, which offers long-lasting protection without requiring regular care. As a result, when people choose contraceptive options based on convenience and efficacy, healthcare providers are seeing an increase in demand for subdermal implants. This spike in demand emphasizes how important it is to satisfy user desires for dependable and hassle-free birth control methods, and how important it is that high efficacy plays in determining the landscape of contraceptive options.

Global Subdermal Contraceptive Implants Market Restraints and Challenges:

The growth potential of the global subdermal contraceptive implant market is tempered by several significant challenges. Foremost among these are concerns surrounding potential side effects, such as irregular bleeding and hormonal fluctuations, which can deter potential users despite the method's efficacy. Moreover, in regions with limited access to comprehensive sex education, a lack of awareness about subdermal implants persists, hindering adoption rates. Privacy concerns surrounding the implant's insertion and the potential stigma associated with long-term contraception, particularly in certain cultural contexts, further compound these challenges. Overcoming these obstacles necessitates concerted educational initiatives aimed at raising awareness about the benefits and risks of subdermal implants. Additionally, efforts to improve communication between healthcare providers and potential users are crucial to address concerns, dispel myths, and ensure informed decision-making. By tackling these challenges head-on, the subdermal contraceptive implant market can realize its growth potential and offer a viable birth control option to a broader spectrum of individuals worldwide.

Global Subdermal Contraceptive Implants Market Opportunities:

The global subdermal contraceptive implant market is poised for significant growth, presenting enticing opportunities on multiple fronts. Firstly, the potential for expansion into developing regions with increasing healthcare investments and expanding populations offers a promising avenue. Manufacturers can leverage this by introducing affordable implant options and implementing educational programs tailored to the specific needs of these regions, thereby tapping into a vast pool of potential users. Secondly, ongoing advancements in implant technology, such as the development of biodegradable materials or features facilitating self-removal, hold the potential to further enhance user convenience and drive adoption rates globally. Moreover, strategic collaborations between pharmaceutical companies and healthcare providers can play a pivotal role in improving access to insertion and removal procedures, thus making subdermal implants a more accessible and attractive option for a broader spectrum of women. By capitalizing on these opportunities and embracing innovation and collaboration, the subdermal contraceptive implant market can continue to thrive and meet the evolving needs of women worldwide.

SUBDERMAL CONTRACEPTIVE IMPLANTS MARKET REPORT COVERAGE:

Subdermal Contraceptive Implants Market Segmentation: By Type

• Non-Biodegradable

• Biodegradable

The Global Subdermal Contraceptive Implants Market is Segmented by Type, Non-biodegradable held the largest market share last year and is poised to maintain its dominance throughout the forecast period. The non-biodegradable segment is anticipated to dominate the subdermal contraceptive implant market, primarily due to its cost-effectiveness and high efficacy in birth control, boasting an impressive success rate of around 99%. These implants are typically inserted into the body by certified and trained medical practitioners, ensuring proper placement and efficacy. Removal procedures, likewise, are conducted by medical practitioners who have undergone manufacturer-sponsored training, usually lasting three hours. This seamless process not only contributes to the segment's growth but also instills confidence in users regarding the effectiveness and safety of the method. Furthermore, the non-biodegradable nature of these implants ensures that no traces of birth control practices are left behind once the implant is removed, addressing concerns regarding privacy and discretion. As a result, the non-biodegradable segment continues to see substantial growth, driven by its combination of affordability, high efficacy, and ease of use, making it a preferred choice for individual seeking reliable long-term contraception.

Subdermal Contraceptive Implants Market Segmentation: By End Users

• Hospitals

• Gynaecology Clinics

• Women Healthcare Centers

The Global Subdermal Contraceptive Implants Market is Segmented by End-Use, Gynaecology Clinics held the largest market share last year and is poised to maintain its dominance throughout the forecast period. The gynecology clinics segment is projected to secure a significant portion of the subdermal contraceptive implant market share, driven by a rising number of patient visits for both implantation and removal procedures. These specialized clinics offer tailored services and expertise in reproductive health, making them a preferred choice for individuals seeking subdermal contraceptives. Simultaneously, the hospital segment is expected to capture a substantial share among end-users, buoyed by the availability of advanced diagnostic systems and comprehensive treatment options. Major hospitals worldwide are witnessing an uptick in demand for contraceptive services, with governments increasingly partnering with them to provide affordable male and female contraceptives. Particularly in densely populated countries like India and China, governments are taking proactive measures by offering free contraception to curb population growth and mitigate the spread of sexually transmitted diseases. This collaborative approach between governments and hospitals not only enhances accessibility to contraceptive services but also underscores the critical role of healthcare institutions in addressing public health challenges related to reproductive health and family planning on a global scale.

Subdermal Contraceptive Implants Market Segmentation: By Region

• North America

• Asia-Pacific

• Europe

• South America

• Middle East and Africa

The Global Subdermal Contraceptive Implants Market is Segmented by Region, North America held the largest market share last year and is poised to maintain its dominance throughout the forecast period. Americas currently dominate the world market and will do so for the foreseeable future. Due to the region's growing medical tourism industry, fast-developing healthcare infrastructure, and growing need for contraceptive implants, Central America currently holds the highest proportion. In a similar vein, the market for subdermal contraceptive implants in North America is expanding quickly. Sexually transmitted infections are becoming more common, the infrastructure for healthcare is well-developed, and healthcare costs are rising. Due to their great efficacy, extended term of contraception, and ease of insertion and removal, subdermal contraceptive implants are in high demand in the area. The growing number of working women in the area and the continuous improvements in contraceptive implants are further factors propelling the market. Europe is the market's second place. Leading producers of subdermal contraceptive implants are present in the area and are actively engaged in substantial research and development to ensure the continued production of cutting-edge products. The Northern European nations—Estonia, Finland, Denmark, Latvia, Ireland, Sweden, Norway, United Kingdom of Great Britain, and Northern Ireland—are the main contributors to the subdermal contraceptive implant market, which is driving the market's growth, according to the United Nations-Department of Economic and Social Affairs.

COVID-19 Impact Analysis on the Global Subdermal Contraceptive Implants Market:

The COVID-19 pandemic presented a mixed impact on the subdermal contraceptive implant market, characterized by both disruptions and counterbalancing factors. Initially, lockdown measures and healthcare resource constraints disrupted the insertion procedures for subdermal implants, causing a temporary setback in market activity. However, the prolonged periods of lockdown and increased time spent at home potentially led to a surge in unplanned pregnancies, prompting some women to seek long-acting birth control methods like subdermal implants to regain control over their reproductive health. Nevertheless, anxieties surrounding clinic visits and concerns about exposure to the virus during the pandemic may have deterred some individuals from pursuing these contraceptive options, offsetting the potential increase in demand. As healthcare systems gradually recover and pandemic-related restrictions ease, the market for subdermal contraceptive implants is anticipated to stabilize and resume its pre-pandemic growth trajectory. With improved access to healthcare services and a renewed focus on reproductive health, the demand for long-acting contraceptive methods like subdermal implants is expected to rebound, driving market growth in the post-pandemic era.

Latest Trends/ Developments:

The global subdermal contraceptive implants market is witnessing several significant trends and developments shaping its trajectory. One prominent trend is the increasing emphasis on user-friendly designs and improved insertion and removal procedures, aimed at enhancing patient experience and satisfaction. Manufacturers are investing in research and development to introduce advancements such as smaller implant sizes, smoother insertion techniques, and simplified removal processes, all contributing to greater convenience and accessibility for users. Additionally, there is a growing focus on expanding market reach into developing regions through strategic partnerships and educational initiatives, recognizing the untapped potential in these areas. Moreover, the integration of digital health technologies, such as mobile apps for tracking implant effectiveness and scheduling follow-up appointments, is gaining traction, providing users with greater autonomy and support in managing their contraceptive choices. Furthermore, heightened awareness and advocacy efforts surrounding reproductive health and family planning are driving increased acceptance and adoption of subdermal implants, particularly among younger demographics. These trends collectively indicate a dynamic and evolving landscape for subdermal contraceptive implants, with innovations and initiatives aimed at meeting the diverse needs and preferences of users worldwide.

Key players:

1. Shanghai Dahua Pharmaceutical Co., Ltd.

2. Bayer AG

3. Organon

4. Novartis AG

5. Pfizer (Wyeth Pharmaceuticals Inc.)